The Surprise That Sent Vertex — And Its Chief Rival — Soaring

Vertex stock popped Tuesday — while shares of rival Maze Therapeutics skyrocketed — on a surprise expansion for their kidney disease drugs. The post The Surprise That Sent Vertex — And Its Chief Rival — Soaring appeared first on Investor's Business Daily.